Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “QT Effects in Healthy Volunteers”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00839891
What this trial is testing

Evaluate How VI-0521 Affect Cardiac Repolarization in Healthy Male and Female Volunteers

Who this might be right for
Torsades de Pointes
VIVUS LLC 112
Early research (Phase 1)Study completedNCT01398293
What this trial is testing

Danoprevir in Combination With Low-Dose Ritonavir in Healthy Subjects

Who this might be right for
Healthy Volunteer
Hoffmann-La Roche 52
Early research (Phase 1)Study completedNCT04175808
What this trial is testing

Study to Assess the Effect of Omecamtiv Mecarbil (OM) on QT/QTc Intervals in Healthy Adults

Who this might be right for
QT Intervals ChangesQTc Intervals Changes
Cytokinetics 70
Early research (Phase 1)Study completedNCT00809289
What this trial is testing

Phase 1 Thorough QT (TQT) Study in Young Healthy Volunteers

Who this might be right for
Fibromyalgia
Pfizer 40
Early research (Phase 1)Study completedNCT00850746
What this trial is testing

Evaluate the Effect of Repeat Oral Doses of YM443 on Cardiac Repolarization in Healthy Adults

Who this might be right for
Functional Dyspepsia
Astellas Pharma Inc 80
Early research (Phase 1)Study completedNCT00672399
What this trial is testing

Electrophysiological Effects of a Single 10 μg Dose of Exenatide on the 12-Lead Electrocardiogram QT Interval in Healthy Subjects

Who this might be right for
Healthy Subjects
AstraZeneca 70
Early research (Phase 1)Study completedNCT04688632
What this trial is testing

Thorough QT Study to Evaluate Ampreloxetine in Healthy Subjects

Who this might be right for
Symptomatic Neurogenic Orthostatic HypertensionnOH
Theravance Biopharma 72
Early research (Phase 1)Study completedNCT01290900
What this trial is testing

A Single-centre, Randomised, Double-blind, Placebo-controlled, Four Way Crossover Phase I Study to Investigate the Effect on QT/QTc Interval of Ceftazidime NXL104 or Ceftaroline Fosamil NXL104, Compared With Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Volunteers

Who this might be right for
Healthy Male Volunteers
Pfizer 54
Early research (Phase 1)Study completedNCT06822153
What this trial is testing

Clinical Trial of the Effect of Methoxyethyl Etomidate Hydrochloride on the QT Interval of the Heart

Who this might be right for
QT Interval, Variation in
Ahon Pharmaceutical Co., Ltd. 18
Early research (Phase 1)Study completedNCT03822520
What this trial is testing

Clinical Study to Evaluate Effect on QT/QTc Interval After Multiple Dose of Celecoxib

Who this might be right for
Qt Interval, Variation in
Samsung Medical Center 28
Early research (Phase 1)Study completedNCT02508753
What this trial is testing

Safety Study Designed to Study the Effects of Two Different Doses of CXA-101/Tazobactam, a Low Dose and a High Dose, on the QT/QTc Intervals in Healthy Subjects

Who this might be right for
Healthy
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 52
Early research (Phase 1)Study completedNCT02651623
What this trial is testing

Study to Evaluate The Effect Of Sertraline on the Cardiac Repolarization in Healthy Subjects

Who this might be right for
Healthy
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 54
Early research (Phase 1)Study completedNCT03258515
What this trial is testing

Investigate the Effect of Single Dose of AZD6094 (600 mg) on Cardiac Repolarization in Healthy Volunteers

Who this might be right for
Solid Tumors
AstraZeneca 45
Early research (Phase 1)Study completedNCT00543062
What this trial is testing

Staccato Prochlorperazine Thorough QT/QTc

Who this might be right for
Cardiotoxicity
Alexza Pharmaceuticals, Inc. 48
Early research (Phase 1)Study completedNCT01265641
What this trial is testing

To Investigate the Effects of AZD1981 on the QT Interval

Who this might be right for
Asthma
AstraZeneca 44
Early research (Phase 1)Study completedNCT05933447
What this trial is testing

Thorough QT Study to Evaluate the Effect of Rodatristat Ethyl, Rodatristat and Its Major Metabolites on the Heart

Who this might be right for
Healthy
Altavant Sciences GmbH 27
Early research (Phase 1)Study completedNCT01191723
What this trial is testing

QT Intervals Study to Compare the Acute Effects of Orally Inhaled Dihydroergotamine (DHE), Oral Moxifloxacin, and Placebo

Who this might be right for
Healthy
Allergan 54
Early research (Phase 1)Study completedNCT01487135
What this trial is testing

Phase 1 Study to Assess the Effects of EVP-6124 on the QT/QTc Interval in Healthy Subjects

Who this might be right for
Healthy SubjectsCardiac Repolarization
FORUM Pharmaceuticals Inc 60
Early research (Phase 1)Study completedNCT06411860
What this trial is testing

Assess the Effect of Olpasiran on QT/QTc Intervals in Healthy Participants

Who this might be right for
Basic Science
Amgen 32
Early research (Phase 1)Study completedNCT05830071
What this trial is testing

A Thorough QT (TQT) Study of CHF5993 pMDI in Healthy Volunteers (HV)

Who this might be right for
AsthmaChronic Obstructive Pulmonary Disease (COPD)
Chiesi Farmaceutici S.p.A. 95
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation